Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 441.75 | -57.22 | -78.83 | 66.45 | 39.38 | 26.28 |
PEG Ratio | -3.60 | -2.68 | 0.42 | -2.47 | -0.76 | -2.91 |
PS Ratio | 3.35 | 2.34 | 3.06 | 4.43 | 3.94 | 4.68 |
PB Ratio | 4.55 | 3.03 | 3.43 | 4.45 | 3.58 | 6.61 |
P/FCF Ratio | 23.36 | -267.85 | -40.02 | 44.45 | 37.09 | 14.53 |
P/OCF Ratio | 23.03 | -386.64 | -43.40 | 40.54 | 20.71 | 11.88 |
OCF/S Ratio | 14.54 | -0.60 | -7.05 | 10.92 | 19.03 | 39.41 |
Debt / Equity Ratio | 0.42 | 0.51 | 0.78 | 0.81 | 0.84 | 0.88 |
Quick Ratio | 2.03 | 3.02 | 3.33 | 3.94 | 4.75 | 3.15 |
Current Ratio | 2.59 | 3.77 | 4.06 | 4.65 | 5.33 | 3.43 |
Asset Turnover | 0.75 | 0.72 | 0.53 | 0.48 | 0.44 | 0.62 |
Interest Coverage | 1.95 | -0.41 | -3.74 | 1.84 | 2.72 | 7.40 |
Return on Equity | 1.03% | -5.17% | -4.82% | 6.68% | 7.31% | 25.14% |
Return on Assets | 0.57% | -2.86% | -2.28% | 3.21% | 3.55% | 11.02% |
Return on Invested Capital | 1.05% | -1.06% | -5.01% | 2.42% | 3.27% | 23.07% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 87.90% | 88.09% | 89.72% | 91.46% | 89.37% | 88.91% |
Net Profit Margin | 0.76% | -3.98% | -4.30% | 6.65% | 8.04% | 17.79% |
Pretax Profit Margin | 3.42% | -2.86% | -4.90% | 7.29% | 11.60% | 20.78% |
Operating Profit Margin | 5.55% | -1.23% | -9.09% | 4.80% | 9.56% | 35.94% |
FCF Margin | 14.34% | -0.87% | -7.65% | 9.96% | 10.62% | 32.20% |
EBITDA Margin | 9.25% | 5.49% | 4.03% | 16.31% | 24.53% | 27.50% |
Add to Watchlist
Select watchlists to add or remove PHAR